Evidence map›Paper›PMID 10803460›Full record

ArticleOncogene2000

Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.

E Sadot, I Simcha, K Iwai, A Ciechanover, B Geiger, A Ben-Ze'ev

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Molecules (Basel, Switzerland) · 2019
    Article
  3. Review
  4. Review
  5. Molecular and cytoskeletal regulations in epidermal development.Seminars in cell & developmental biology · 2017
    Review
  6. Pathogenesis of Arrhythmogenic Cardiomyopathy.The Canadian journal of cardiology · 2015
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. The noncanonical NF-κB pathway.Immunological reviews · 2012
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Desmosomes at a glance.Journal of cell science · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

E SadotDepartment of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.
I Simcha
K Iwai
A Ciechanover
B Geiger
A Ben-Ze'ev
Weizmann Institute of Science · ILKyoto University · JPTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beta-catenin and plakoglobin are closely related armadillo family proteins with shared and distinct properties; Both are associated with cadherins in actin-containing adherens junctions. Plakoglobin is also found in desmosomes where it anchors intermediate filaments to the desmosomal plaques. Beta-catenin, on the other hand, is a component of the Wnt signaling pathway, which is involved in embryonic morphogenesis and tumorigenesis. A key step in the regulation of this pathway involves modulation of beta-catenin stability. A multiprotein complex, regulated by Wnt, directs the phosphorylation of beta-catenin and its degradation by the ubiquitin-proteasome system. Plakoglobin can also associate with members of this complex, but inhibition of proteasomal degradation has little effect on its levels while dramatically increasing the levels of beta-catenin. Beta-TrCP, an F-box protein of the SCF E3 ubiquitin ligase complex, was recently shown to play a role in the turnover of beta-catenin. To elucidate the basis for the apparent differences in the turnover of beta-catenin and plakoglobin we compared the handling of these two proteins by the ubiquitin-proteasome system. We show here that a deletion mutant of beta-TrCP, lacking the F-box, can stabilize the endogenous beta-catenin leading to its nuclear translocation and induction of beta-catenin/LEF-1-directed transcription, without affecting the levels of plakoglobin. However, when plakoglobin was overexpressed, it readily associated with beta-TrCP, efficiently competed with beta-catenin for binding to beta-TrCP and became polyubiquitinated. Fractionation studies revealed that about 85% of plakoglobin in 293 cells, is Triton X-100-insoluble compared to 50% of beta-catenin. These results suggest that while both plakoglobin and beta-catenin can comparably interact with beta-TrCP and the ubiquitination system, the sequestration of plakoglobin by the membrane-cytoskeleton system renders it inaccessible to the proteolytic machinery and stabilizes it.

Indexed as

Trans-ActivatorsAnimalsbeta Cateninbeta-Transducin Repeat-Containing ProteinsBiological TransportCell CompartmentationCHO CellsCricetinaeCysteine EndopeptidasesCytoskeletal ProteinsDesmoplakinsDexamethasoneDNA-Binding Proteinsgamma CateninGTP-Binding ProteinsHumansbeta Cateninbeta-Transducin Repeat-Containing ProteinsBTRC protein, humanCTNNB1 protein, humanCysteine EndopeptidasesCytoskeletal ProteinsDesmoplakinsDexamethasoneDNA-Binding Proteinsgamma CateninGTP-Binding ProteinsLymphoid Enhancer-Binding Factor 1Multienzyme ComplexesOctoxynolProteasome Endopeptidase ComplexRecombinant ProteinsTrans-ActivatorsTranscription FactorsUbiquitins

Identifiers

PMID10803460
OpenAlexW2064367394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.